Understand title risk before committing capital or assuming liability.
Diagnostics are paid by the investor or end buyer—not by wholesalers. Pre-acquisition diagnostics document title risk, cure costs, and resolution timelines before capital deployment, enabling data-driven acquisition decisions and risk-adjusted pricing.
Title Rescue Desk is not a law firm and does not provide legal advice. We provide factual diagnostic analysis used by investors and their counsel to assess acquisition risk and determine deal feasibility.
Your deal is in trouble. Title issues have emerged, the closing is at risk, and you're unsure if the deal can be salvaged. Submit your file for an objective assessment of whether this deal can be rescued.
Rescue My DealYou have a deal with title problems. Before you walk away or overpay, let us assess what it would actually take to clear this title. Get the real numbers before making your decision.
Submit Problem DealImportant: Title Rescue Desk is not a law firm and does not provide legal advice. We provide diagnostics and title-readiness services that help investors make informed decisions.
Distressed properties often carry title defects that surface only after acquisition—probate gaps, undisclosed liens, tax delinquencies, or chain-of-title breaks that prevent marketable title. Investors who acquire without diagnostic analysis face capital loss when properties cannot be resold or refinanced.
Title insurance may not issue on properties with known defects. Lenders refuse financing on unmarketable title. Legal fees for cure attempts can exceed property value. Holding costs accumulate while title issues remain unresolved.
Pre-acquisition diagnostics reduce this risk. Investors receive written documentation of title defects, estimated cure costs, and resolution timelines before committing capital— enabling informed go/no-go decisions or risk-adjusted purchase price negotiations.
Systematic documentation of all title impairments—probate gaps, liens, tax issues, chain-of-title breaks, and encumbrances preventing marketable title.
Each defect assigned risk rating based on curability, legal complexity, estimated cost, and resolution timeline. Ratings inform acquisition risk assessment.
Documented resolution pathways (probate, quiet title, administrative) with cost and timeline estimates—or documented determination that property is terminal.
Order diagnostics before closing—not after acquisition. Pre-acquisition diagnostics enable informed go/no-go decisions and risk-adjusted pricing negotiations before capital commitment.
Diagnostics are paid by the investor or end buyer—not by wholesalers. The party acquiring the property pays the diagnostic fee upfront.
Diagnostic fees are not contingent on closing. Fee is earned for research and analysis— regardless of whether acquisition proceeds. Some diagnostics conclude deals should be abandoned.
Fast-track analysis for urgent auction deadlines or contract contingencies requiring immediate go/no-go determination.
Full-depth diagnostic with systematic defect inventory, A–D risk ratings, and documented cure pathways with cost estimates.
Master Service Agreements for funds and institutional buyers requiring volume diagnostic support with defined SLAs.
Not all properties can achieve marketable title. Some title defects are terminal—impossible or economically impractical to cure. When diagnostic analysis reveals such defects, we document this as a no-go determination with supporting reasoning.
Walk-away determinations protect investor capital by providing documented justification for abandoning acquisitions where cure costs exceed property value, legal remedies are unavailable, or resolution timelines are indefinite.
The diagnostic fee is earned for clarity—not for positive outcomes. Investors pay for research and analysis that sometimes reveals a property should not be acquired. This clarity prevents larger capital losses post-acquisition.
No guarantee of resolution. Diagnostics document title risk and potential resolution pathways— not guarantees of successful cure. Walk-away determinations are a documented outcome protecting investor capital from properties that cannot economically achieve marketable title.
Protect your capital with documented title risk analysis before closing.